Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Warren Olanow

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|October 17, 2015
MDS clinical diagnostic criteria for Parkinson's diseaseRonald B Postuma, Daniela Berg, Matthew Stern, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2021
Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND StudyWerner Poewe, Fabrizio Stocchi, David Arkadir, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 22, 2007
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task forceBruno Dubois, David Burn, Christopher Goetz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 17, 2015
MDS research criteria for prodromal Parkinson's diseaseDaniela Berg, Ronald B Postuma, Charles H Adler, et al.
Annals of Neurology|June 11, 2015
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trialC Warren Olanow, Raymond T Bartus, Tiffany L Baumann, et al.
The Lancet. Neurology|March 18, 2024
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trialAlberto J Espay, Fabrizio Stocchi, Rajesh Pahwa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 2007
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patientsPablo Martinez-Martin, Anthony H V Schapira, Fabrizio Stocchi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2006
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing planChristopher G Goetz, Stanley Fahn, Pablo Martinez-Martin, et al.
The Lancet. Neurology|October 26, 2010
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialWilliam J Marks, Raymond T Bartus, Joao Siffert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2008
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing resultsChristopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Movement Disorders : Official Journal of the Movement Disorder Society|October 17, 2015
MDS clinical diagnostic criteria for Parkinson's diseaseRonald B Postuma, Daniela Berg, Matthew Stern, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2021
Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND StudyWerner Poewe, Fabrizio Stocchi, David Arkadir, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 22, 2007
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task forceBruno Dubois, David Burn, Christopher Goetz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 17, 2015
MDS research criteria for prodromal Parkinson's diseaseDaniela Berg, Ronald B Postuma, Charles H Adler, et al.
Annals of Neurology|June 11, 2015
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trialC Warren Olanow, Raymond T Bartus, Tiffany L Baumann, et al.
The Lancet. Neurology|March 18, 2024
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trialAlberto J Espay, Fabrizio Stocchi, Rajesh Pahwa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 2007
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patientsPablo Martinez-Martin, Anthony H V Schapira, Fabrizio Stocchi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2006
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing planChristopher G Goetz, Stanley Fahn, Pablo Martinez-Martin, et al.
The Lancet. Neurology|October 26, 2010
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialWilliam J Marks, Raymond T Bartus, Joao Siffert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2008
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing resultsChristopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, et al.
Pageof 15